Rapid communication · 25 Sep 2023
Conference abstractPublished 12 Nov 2012
Exploring new targeted therapeutic agents for SLE
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
I nterferon regulatory factor 5 (IRF5) polymorphisms are strongly associate with an increased risk of systemic lupus erythematosus (SLE). IRF5 plays an essential role in pathogenesis in experimental lupus mouse model through type I IFN production dependent and independent ways. The critical role of TLR7 in acceleration of SLE was already established. Thus, the molecules involved in TLR7 and IRF5 signaling pathway are potential therapeutic targets for lupus. In present study, we firstly set up luciferase immunoprecipitation system (LIPS) assay for detecting anti-U1A autoantibody in culture supernatant of B cells stimulated by TLR7 ligand, R848. An IFN beta promoter reporter system was used to monitor type I IFN production. Our results showed MyD88 homodimerization inhibitory peptide could significantly inhibit human anti-U1A autoantibody production from B cells stimulated by R848 in vitro. The kaposi?s sarcoma-associated herpesvirus encoded vIRF3 and IRF5 variant 12 (IRF5-V12) could significantly inhibit type I IFN production stimulated by R848. Moreover, the central 70 amino acids of vIRF3 and the first 100 amino acids of IRF5-V12 are sufficient for suppressing R848 stimulated type I IFN production. The role of vIRF3 and IRF5-V12 in suppressing anti-U1A autoantibodies production stimulated by R848 was under investigation. These results indicate that MyD88 inhibitor and IRF5 inhibitors are promising therapeutic agents for SLE
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 29 Mar 2023
Orthopoxvirus Targets for the Development of New Antiviral Agents
Opinion · 29 Dec 2023
Integrating Research and Therapeutic Strategies: Exploring Cellular Targets in Precision Oncology
Conference abstract · 2019
Baculovirus as a new stand-alone prophylactic and therapeutic immunostimulatory agent against malaria
Article · 1 Feb 2024
Targeting Novel Pathways: Investigating the Therapeutic Potential of a New Class of Anticancer Agents
More from this journal
The newest in Journal of Cell Science & Therapy.
Perspective · 2 Feb 2026
Exploring Senescence and Its Influence on Tissue Function and Therapeutic Research
Commentary · 2 Feb 2026
Metabolism Regulation and Its Influence on Therapeutic Development in Human Disease
Commentary · 2 Dec 2025
Cellular Membranes and Transport Proteins as Regulators of Homeostasis and Metabolic Coordination
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Shuhong Han”
- BylineArticles whose byline prints “Westley Reeves”

